During the past decade, St. John's Medical College & Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 16 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. John's Medical College & Hospital" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials, followed by "Population Health Research Institute" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "CymaBay Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Medical College & Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Instituto Grifols, S.A." with 2 trials as a collaborator, "Sintesi Research Srl" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Bill and Melinda Gates Foundation" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "St. John's Medical College & Hospital" are "Stroke" (3 trials), "Systemic Lupus Erythematosus" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Atrial Fibrillation" (2 trials) and "Congenital Afibrinogenemia" (2 trials). Many other conditions were trialed in "St. John's Medical College & Hospital" in a lesser frequency.

Most popular intervention types in "St. John's Medical College & Hospital" are "Drug" (41 trials), "Other" (7 trials), "Biological" (6 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Baricitinib" (3 trials), "Actos" (2 trials), "Aspirin" (2 trials) and "MBX-102" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. John's Medical College & Hospital" are 50 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "St. John's Medical College & Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in St. John's Medical College & Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in St. John's Medical College & Hospital, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".